Jean-Manuel brings more than 20 years of experience in scientific research and medical technology innovation to his work on the Vizua team. While earning his masters degree in neuroscience at Drexel Medical School in Philadelphia, he directed research projects on 3D-reconstruction of neuronal networks and regenerative quantification.Read more >
The nearly blinding pace of technology growth in health care has led to networks of systems and devices that not only help support and maintain human lives, but have also taken on some of the characteristics of the biological systems they interact with. As the patient changes so do the medical devices connected to the patient, and so does the network connected to the medical devices. This interconnected system of man and technology has led to an environment where vulnerabilities in the technological systems can lead to dire consequences for the patient. Like the human systems technology must interact with, the technological systems need to be managed throughout their entire lifecycle, from inception to retirement. Please join this session for an overview of how vulnerabilities can be discovered, and what we need to do to continue managing vulnerabilities throughout the lifecycle of a healthcare system.Read more >
Join this webinar to learn more about
• The IoT Medical Device Market
• Business Drivers and Requirements for a Medical IoT platform
• A Solutions Showcase of a Medical IoT platform
Today, billions of devices are connected to the Internet and their device logs can be mined to reveal accurate product usage & operational data along with feature adoption by facility and physician behavior across the installed base. This valuable information can be leveraged across the enterprise to decrease support costs and increase service revenues creating a high-impact ROI solution for a medical enterprise.
Personalized healthcare continues to evolve. There are now five pillars of cancer therapy and two of the five, targeted therapies and immunotherapy, are personalized approaches. Join us at 9 AM MST, February 25, 2016 as Eric Walk MD, FCAP, Chief Medical Officer, Ventana Medical Systems, Inc. (Ventana), addresses how personalized healthcare has evolved and impacted cancer diagnosis and therapy.Read more >
Retrieving medical records from providers can be the most challenging aspect of the HEDIS hybrid measure season and its success can have the most direct impact on hybrid rates. Learn ways to improve your chart retrieval processes to increase your success at receiving your member’s medical records during the busy HEDIS season.Read more >
Join expert medical librarian Amanda Horsman and Doug Felder from Mendeley for an exclusive webinar focused on how librarians like you use Mendeley Institutional Edition to support students and researchers. Amanda will demonstrate the power of facilitating inter-professional collaboration between research group members.Read more >
How automatic is your automation?
In part one of this webinar, Freddie Cardel outlines the concept of automatic plan generation with Plan Explorer and demonstrates a completely new level of automation. He explains the approach, where large numbers of high-quality treatment plans are automatically generated for defined clinical goals and combinations of treatment techniques and machines, and shows how these plans can be easily filtered and browsed to find the most suitable candidates to be evaluated.
In part two, Erik Korevaar and Roel Kierkels present the first findings of the clinical evaluation they performed at University Medical Center Groningen, the Netherlands, and describe how the center envisions the use of the tool in clinical practice.
During radiation therapy, the patient’s anatomical state is not static. Many different factors contribute to a shifting picture, and it is essential to account for uncertainties in order to ensure the quality of the treatment plan.
In the first half of this webinar, Niek Scheuder, Chief Medical Physicist, will share his experience from implementing an adaptive planning workflow with RayStation at the Provision Center for Proton Therapy.
In the second half, Cameron Ditty, Senior Physicist, will explain the concept of robustness in RayStation, illustrating with practical examples.
Robust optimization handles possible variations that are not sufficiently accounted for by PTV. The resulting plan maintains target coverage while reducing dose to critical structures, even if anatomical changes or positional errors occur.
Propelled by the need to personalize medical care, more and more targeted therapies and companion diagnostics are being developed. What are the key considerations for successful co-development of companion diagnostics and targeted therapies? Join Abigail McElhinny PhD, Vice President Development, Ventana Medical Systems Inc., and Steffan Ho, MD, PhD, Executive Director, Early Development, Translational and Immuno-Oncology, Pfizer Oncology, Pfizer Inc., on November 12, 2015, 9 AM Phoenix time as they address biological, development, regulatory, and other considerations that are indispensable for success.Read more >
Medical doctor Dheerandra Prasad talks about clinical prospects and his clinical experience of the Leksell Gamma Knife® Icon™ for precise, frameless and frame-based stereotactic radiosurgery of the brain.
Leksell Gamma Knife Icon combines the unprecedented accuracy of Gamma Knife with integrated immobilization, workflow and imaging technologies to provide even greater clinical flexibility for brain radiosurgery. This is due to a number of advancements, including on-board cone beam computer tomography, a thermoplastic mask system and an infrared-based high-definition motion-management system for patient tracking during treatment, which provide the opportunity to perform frameless and fractionated radiosurgery, as well as frame-based and single-session treatments, and to perform online adaptive planning.
Based on his experience as a radiation oncologist and a neurosurgeon, Dr Prasad discusses how these novel features of Gamma Knife Icon have opened up the possibility of extending Gamma Knife treatment to more patients and new indications. He will explain how the on-board CBCT imaging capabilities of Gamma Knife Icon have improved imaging workflows for both frame-based and frameless treatments at his clinic, and how the thermoplastic mask system has enabled him to treat targets outside the range of frame fixation. He also will describe how the ability to fractionate treatments has allowed him to expand his case mix, for example to patients with tumours that are situated close to critical structures, allowing such patients to benefit from the superior dosimetry of Gamma Knife.
Drawing from individual case studies and his personal experience, Dr Prasad will illustrate how Leksell Gamma Knife Icon is a valuable and flexible tool for brain radiosurgery and its role alongside linac-based stereotactic radiotherapy in today’s radiation oncology centres.
This webinar will provide you with an overview how digital can be integrated into medical plans and what it takes to deliver multichannel medical excellence at launch.
Key topics include:
•Overview of typical launch categories and their key communication drivers and multichannel opportunities
•The 4 main pre-launch stakeholders and how to integrate digital initiatives in a balanced medical mix whilst respecting legal and regulatory guidelines
oeKOLs: Gathering insight and engagement planning
oeHCPs: Channel selection to ensure immersive learning and education
oePatients: Gathering treatment insight and prepare education & value-focused “beyond the-pill” strategies for launch
oePayers: Establish value
•Assess the clinical impact of e-medical programmes and how to create KPIs and dashboards to assess the success of your cross-channel activities
•Prepare your organization for emedical excellence through multichannel skills development and enablement for MSLs and internal staff
Attend this webinar to discover:
·Insight from BRIC healthcare leaders as they share field experiences and best practices gathered through hundreds of successful cases
·Common obstacles international companies must overcome in these regions
·How to exploit the hidden potential of BRIC countries
·Tactics to adjust strategy to successfully penetrate BRIC markets
·The top 10 technologies and products expected to drive growth in these regions
The rich data in your imaging archive is a resource that has largely been untapped. But now, Dell’s Clinical Cloud Services can help you tap that resource to impact population health and predict hidden risks in your patient population. Using automated machine vision medical image analysis, this new technology identifies patients at risk for chronic diseases such as osteoporosis, heart disease and other conditions, possibly well ahead of overt symptoms. Think of the value this could bring to patients and the advantage it would offer to a healthcare organization in a value-based reimbursement environment. Using existing prescribed imaging studies, Dell’s Imaging Analytics Platform selects appropriate studies that are analyzed for indications of disease presence. The platform makes the results available as reports, which are shared via HL7 or as DICOM objects. These reports are used by primary care physicians and care management program coordinators to provide follow up with patients on diagnostic tests and preventative care programs.Read more >
This briefing will investigate how regulations and hospital needs stimulate the EMR market in Latin America and will specially focus on how these regulations will potentially encourage the EMR implementation until 2017.
Why You Should Attend:
·Learn about the market dynamics of EMR in the region
·Identify the drivers and restraints impacting the EMR market for the next six years
·Discover business opportunities
During a panel discussion on mobility at Dell World, 2015, Dr. Nick van Terheyden, Chief Medical Officer, Dell Services, discusses the future of healthcare with optimism and enthusiasmRead more >
Yes? No? Maybe? Join Dr. James Hnatyszyn on May 26 at 9 AM, Phoenix time to learn more about the impact of NGS on research and clinical diagnostics. Dr. Hnatyszyn is the Senior Director, Companion Diagnostics, Global Laboratory Operations at Ventana Medical Systems Inc. He will review the available NGS technologies and address key issues to consider when using these technologies.Read more >
During a panel discussion on mobility at Dell World, 2015, Dr. Nick van Terheyden, Chief Medical Officer, Dell Services, discusses the future of healthcare with optimism and enthusiasm.Read more >
How One Medical Center Succeeded
2014 North American Surgical Imaging Integration Customer Value Enhancement AwardRead more >
With the advent of NGS and existing molecular approaches, why is IHC unique and relevant for companion diagnostics? January 22, 2015 to learn more from Dr. Mary Padilla, Pathologist, Senior Medical Director, Companion Diagnostics, Ventana Medical Systems Inc. If you provide companion diagnostic services, develop targeted therapies, or prescribe targeted therapies, then this is the webinar for you!Read more >
Arkansas Medicaid Medical Director, Dr. William Golden, addresses Arkansas’ successful Health Care Payment Improvement Initiative.Read more >
How do ischemia and fixation impact the quality of your assay results and information transfer? Garbage in! Garbage out! Join Geoffrey Baird MD, PhD and David Chafin, PhD at 9 AM Mountain Time, March 31, 2015, who will discuss the impact of ischemia and fixation on assay results, information transfer and some novel approaches to address these important factors. Dr. Baird is an Assistant Professor of Laboratory Medicine and an Adjunct Assistant Professor of Pathology at the University of Washington. Dr. Chafin is a Principle Scientist, Technology and Applied Research at Ventana Medical Systems Inc.Read more >
Recordkeeping for purposes of regulatory compliance in the modern radiation oncology environment is largely a paper driven process. Many software and hardware solutions are available from vendors to solve individual issues relating to the collection and processing of QA data, but few, if any, can collect, process and present the results of this data in a cohesive way.
This presentation will show how electronic recordkeeping is readily and routinely used in the setting of Radiology and Nuclear Medicine Service lines, but strangely absent in the Oncology service line. We will attempt to cover current offerings from oncology software vendors that aim to reduce the amount of paperwork and streamline the acquisition and processing of quality assurance data. In addition, we will provide an overview of the solution we are in the process of implementing at our facility.
Goals and Objectives
At the conclusion of the program, participants will be able to:
-Identify the use of electronic recordkeeping in other areas of the hospital setting where radiation and radioactive materials are being utilized.
- Assess the need for some form of comprehensive recordkeeping in Radiation Oncology.
- Assess currently available offerings from vendors.
- Discuss what our facility is implementing to fill this need
Medical Physicists, Oncology IT professionals, Oncology Administrators
Approved for 1 credit ASRT, MDCB, MPCEC
An increasing number of health sciences companies are using social networking and social CRM to reach out to diverse stake-holder groups such as health care professionals, collaboration partners, patients and consumers. While social networking provides an opportunity for engaging stakeholders in a two-way dialogue, regulations nevertheless constrain the content of those conversations. While pharmaceutical companies are starting to leverage social media and benefit from greater interaction with their stakeholders, the medical devices sector is seen as lagging behind.Read more >